To systematically review the effects of probiotics on central nervous system function in animals and humans, to summarize effective interventions (species of probiotic, dose, duration), and to analyze the possibility of translating preclinical studies. Literature searches were conducted in Pubmed, Medline, Embase, and the Cochrane Library. Only randomized controlled trials were included. In total, 38 studies were included: 25 in animals and 15 in humans (2 studies were conducted in both). Most studies used Bifidobacterium (eg, B. longum, B. breve, and B. infantis) and Lactobacillus (eg, L. helveticus, and L. rhamnosus), with doses between 10 9 and 10 10 colonyforming units for 2 weeks in animals and 4 weeks in humans. These probiotics showed efficacy in improving psychiatric disorderrelated behaviors including anxiety, depression, autism spectrum disorder (ASD), obsessive-compulsive disorder, and memory abilities, including spatial and non-spatial memory. Because many of the basic science studies showed some efficacy of probiotics on central nervous system function, this background may guide and promote further preclinical and clinical studies. Translating animal studies to human studies has obvious limitations but also suggests possibilities. Here, we provide several suggestions for the translation of animal studies. More experimental designs with both behavioral and neuroimaging measures in healthy volunteers and patients are needed in the future. 
Introduction
The microbiota, the ecological community of commensal, symbiotic, and pathogenic microorganisms literally sharing our body space, includes more than 10 times the number of host cells to human cells. 1 The majority of the microbiome lives in the gastrointestinal (GI) tract and is composed of 10 100 trillion microorganisms, containing 100 times as many genes as our genome. 2 Symbiosis of the gut microbiota (GM) can maintain a normal physiology in the host, while dysbiosis of the GM can shift the balance and may induce diseases. Recent studies have found a role for the GM in the gut-brain axis, which can alter minds and behaviors through the central ner-by increasing microbiota diversity and beneficial bacteria compositions. [28] [29] [30] Improved GM changes metabolites, such as short-chain fatty acids and tryptophan, which can indirectly improve CNS function. 26, 31 While there are reviews describing effects of probiotics on CNS function, there has been no previous systematic review that analyzes all the current animal and human studies in the field and describes the most effective probiotic interventions. Furthermore, animal studies in this area outnumber human studies, because behavioral experiments in animals are better established and standardized, while clinical studies in humans on this topic started to increase a few years ago and need translation from preclinical studies. How- Figure 1 . Mechanisms of probiotic effects on the central nervous system. Probiotics influence central nervous system (CNS) function through direct and indirect mechanisms. Probiotics affect the hypothalamic-pituitary-adrenal (HPA) axis, by altering corticosteroid (CORT) and/or adrenocorticotropic hormone (ACTH) levels. The immune system is influenced by limited pro-inflammatory cytokine production and inflammation, and this, in turn, has effects on the CNS. Probiotics can also directly alter CNS biochemistry, such as by affecting brain-derived neurotrophic factor (BDNF), c-Fos, g-aminobutyric acid (GABA), 5 hydroxytryptamine (5-HT), and dopamine (DA) levels, thus influencing mind and behavior. The vagus and enteric nerves are also involved in this gut-brain interaction and are affected by certain probiotics. Probiotics manipulate the gut microbiota (GM) by increasing microbiota diversity and beneficial bacteria composition. An "improved" GM changes metabolites, such as shortchain fatty acids (SCFAs) and tryptophan, and so improves CNS function indirectly. The GM also interacts with the endocrine, immune, and neural systems. ever, from preclinical animal models to clinical trials in humans, there is no direct translation. To bridge the gap between preclinical and clinical studies, a systematic review is needed to summarize effective probiotic interventions on CNS function. We first sought to describe CNS functions that can be influenced by probiotics. Second we provide information about probiotic interventions including strain, dosage, and duration. Furthermore, we analyze and discuss the potential translation of animal models to human studies.
Methods

Search Strategy
This systematic review was conducted according to guidelines of the "Cochrane Handbook for Systematic Reviews of Interventions", following the Preferred Items for Systematic Reviews and Meta-analysis guidelines. 32, 33 Relevant studies were found by searches in the Pubmed, Medline, Embase, and Cochrane Library databases. Articles from 1950 to April 2016 were initially searched using the search terms "(probiotic OR gut microbiota) AND (behavior OR central nervous system)". Additional citations were sought using references in articles retrieved from searches. We only included articles written in English. The first search was undertaken by analyzing text words contained in the title and abstract, and of the key words describing the articles. The second search was conducted according to the citations from all identified reports and relevant review articles.
Study Selection
We included all animal and human studies using different strains of probiotics. In human studies reports of both healthy volunteers and patients were considered.
The abstracts of the retrieved papers were screened for matching the following criteria: (1) the study included a probiotic intervention and (2) the study tested CNS function. After exclusion of non-relevant studies, the remaining articles were screened for the following criteria: (1) the study was described as a randomized controlled study (RCT), (2) the study was described as double-blind if studied in human participants, (3) the study involved use of probiotics in single-and/or multi-strains and those that only used prebiotics or antibiotics were not included, and (4) the study included measures of behavioral experiments, neuropsychological measures (eg, electroencephalography, magnetoencephalography, and functional magnetic resonance imaging). Those that only involved neurophysiological measures were not included in the qualitative analysis but only in the Discussion (eg, measuring neurochemical level, HPA axis activity) because different studies tested quite divergent aspects of lower-level CNS activity.
Data Collection and Analysis
A data extraction and assessment form from the Cochrane Collaboration was used to further exclude inappropriate studies and to extract data we needed to analyze. 33 Double extraction of data was conducted: important data included the source of participants (animal species/strains, patient types), intervention groups (probiotic, placebo, or any other intervention), sample size, duration of interventions, and outcomes (behavioral changes as the primary outcome and lower-level changes [eg, biochemical changes] as secondary outcomes).
We assessed the quality of each study included using the Quality Assessment Tool for Quantitative Studies and the Quality Assessment Tool for Quantitative Studies Dictionary developed by The Effective Public Health Practice Project (EPHPP) (National Collaborating Centre for Methods and Tools [2008] ). 34 The inclusion of both animals and human studies resulted in great heterogeneity of participants, interventions, and CNS functions measured. The outcomes of each study were described. A qualitative synthesis of selected studies was made with the aim of coming to conclusions about which probiotic interventions, at which dose, and for how long, were more/most effective with regard to certain CNS functions. Because of the heterogeneity of designs a meta-analysis was deemed to be inappropriate.
Results
In total, 46 potentially relevant citations were obtained through the primary search strategy, which included animal and human studies, after excluding reviews (n = 98) (systematic reviews, narrative reviews, respective reviews, and systematic reviews and meta-analyses), other articles including comments, hypotheses, viewpoints, opinions, and editorials (n = 13), studies without the use of a probiotic (n = 33), and studies not focusing on CNS function (n = 16) (Fig. 2) . Many articles concerned the potential, and demonstrated mechanisms of the effects, of GM and/or probiotics on CNS function. However, we only included studies that clearly described probiotics as interventions, and excluded studies only measuring GM composition when investigating CNS function. After the full screen, 8 more studies were excluded: four studies lacked a control arm or blinding, and 4 studies did not measure CNS functions at the behavioral level. In total, 38 studies remained for the qualitative analysis. Of them, 15 were in humans and 25 were in animals (2 studies were conducted in humans and animals).
Animal Studies
Of the 25 studies, 19 provided explicit information in the Materials and Methods section on the numbers of animals allocated to each treatment group, and they accounted for all the animals in their results, while 6 studies provided specifics regarding treated animals only in the pertinent areas of the Results section. Results from the quality assessment tool for quantitative studies showed all studies were strong in global ratings for selection bias, study design, confounders, blinding, data collection method, and withdrawals and dropouts (no weak rating): 15 studies described assigning animals randomly to treatment groups or control, although these animal studies were supposed to be RCTs. Only four studies might have confounders because they used both male and female animals while the other studies only used single gender animals, excluding the effect of gender on the results. Only 13 studies reported that experimenters were blinded toward the interventions or exposure status of the participants (we included the other 12 studies that did not describe blinding, because animals were not aware of the research question or intervention, and we ignored potential effects of the experimenter). Data collection tools shown in all studies were considered valid and reliable; no study reported withdrawals or drop outs.
Although all of studies examined were on rodents (mice or rats), the selection of animals was heterogeneous in some respects: strains of animals and health conditions of the animals. Studies were also heterogeneous in the CNS functions they were looking at, the experimental models they used, the probiotics they used, and the dose and duration of the probiotic interventions. Due to the heterogeneity of the included studies, we only described the results based on the interventions and measurements of the CNS functions ( Table 1) .
Most of the studies (18/25) investigated the effects of a single strain of probiotics. In 18 studies using single-strain probiotics, seven used Bifidobacterium, eleven used Lactobacillus, and one used Clostridium (one used both Bifidobacterium and Lactobacillus). Almost all the studies found significant effects on measured CNS functions, except for one testing effect of Bifidobacterium infantis on depression-like behavior. 
Anxiety
Twelve studies tested anxiety-like behavior in animals (mice or rats). The anxiety-like behaviors were evaluated with the elevate plus/Barnes maze, light/dark box, defensive burying, open field/ arms, fear conditioning, and step-down tests. Three of them used a single strain of Bifidobacterium longum, all with positive results, ie, the animals showed less anxious behavior. 22, 35, 36 Two studies using
Lactobacillus helveticus also found reduced anxiety-like behaviors in immune-deficient mice and chronically restrained rats. 29, 37, 38 Two studies used Lactobacillus rhamnosus but only one showed reduced anxiety behaviors. 23, 35 Two studies using Lactobacillus plantarum also found alleviated anxiety levels in mice after the intervention. 20, 21 Bifidobacterium breve and Lactobacillus fermentum were used once each and showed anxiolytic effects. 30, 36 Two studies using multi-strain probiotic combinations of L. rhamnosus + L. helveticus and B. longum + L. helveticus found reduced anxious behavior.
29,39
Depression Nine studies focused on depression and all reported positive results except one. Depression-like behaviors were measured with the tail-suspension, forced-swim, and sucrose-preference tests. B. infantis was used twice but only one study found reduced depressionlike behavior. Each of the single strains of B. longum, B. breve, L. rhamnosus, and L. helveticus was also used once and all showed antidepressant effects. 23, 26, 27, 36, 40 Two studies tested L. plantarum, but it only had an effect in mice with the early life stress of maternal separation. 20, 21 One study used a multi-strain combination of B.
longum + L. helveticus and also showed positive effects. 41 
Cognitive function
Eleven studies tested cognitive function, and all showed the probiotics to be beneficial for memory performance. Spatial memory was tested with the Morris water maze and the Barnes maze tests; other non-spatial memory abilities were measured with the novel object, fear conditioning, passive avoidance step-down, and T-maze tests.
Single strains of B. longum, B. breve, and L. helveticus were effective on both spatial and non-spatial memories. 37 Autism spectrum disorder and obsessive-compulsive disorder
Autism spectrum disorder-related behaviors were tested with the open field and marble-burying tests for anxiety, the pre-pulse inhibition test for sensorimotor, ultrasonic vocalization for communicative, and the three-chamber social test for social interaction behaviors. Bifidobacterium fragilis improved behaviors related to the ASD in maternal immune activation mice, including anxietylike behavior, sensory gating and communicative behavior, but not social interaction behavior. 31 Obsessive-compulsive disorder-related behaviors were also measured with the open field, marble burying, pre-pulse inhibition, ultrasonic vocalization and 3-chamber social tests. L. rhamnosus was found to be able to decrease obsessive-compulsive disorder-like behaviors in mice, but only locomotor ability and anxiety level. No effect was found in communicative or social interaction behaviors. 48 However, a recent study investigated sickness behavior using a social investigative behavior paradigm, and found VSL#3 improved sickness behavior with increased social exploratory behaviors. 49 
Stress response
Four studies involved stress induction to test behavioral response to stress. Stress was induced, with water avoidance stress as an acute stressor 29, 45, 50 and maternal separation as a chronic stressor. 27 Acute stress was used to induce anxiety, memory dysfunction and HPA response; chronic stress was used to induce depression. Anxiety behavior was not successfully induced by water avoidance stress, while memory dysfunction was induced only in Gareau's study. 45 A probiotic combination of L. rhamnosus + L.
helveticus prevented non-spatial memory dysfunction induced by acute stress. 45 One study only measured plasma corticosterone levels in response to acute stress and found a significant decrease due to Lactobacillus casei Shirota intervention. 50 For behavioral changes caused by chronic stress exposure, B. infantis normalized depression-like behavior induced by maternal separation.
Mechanisms of action
In addition to outcomes on behavioral levels, we also collected data at the physiological level, exploring endocrine, immune, neural chemical, and metabolic changes due to probiotics. Most of the studies investigated serum corticosteroid levels and found they were decreased by various probiotics: L. plantarum, L. helveticus, L. fermentum, L rhamnosus, and L. casei Shirota. 20 found effects of L. rhamnosus and B. longum that were mediated via the vagus nerve (ie, no effect in vagotomized mice), 22, 23 and one study found L. casei Shirota to enhance gastric vagal afferent activity. 50 Enteric neuron excitability was inhibited by B. longum, 22 while visceral sensitivity by colon distension was unaffected. 43 One study found that a probiotic formulation of B. longum + L. helveticus reduced intestinal barrier permeability. 31, 41 Probiotics L. helveticus, B.
infantis, and B. fragilis influenced metabolites by enhancing serum tryptophan levels and inhibiting its metabolites. 26, 31, 42 Several studies conducted microbiota analyses on the fecal samples and found fecal microbiota were altered by probiotics: for example, Bacteroides and Lactobacillus were increased and Firmicutes decreased by L. fermentum. [29] [30] [31] 44, 45 More details are shown in Table 1 .
Human Studies
In total, 15 human studies were included. All of the selected studies had strong ratings in the quality assessment tool for quantitative studies, although one of the studies did not describe the age and gender of the participants in each group. 51 Among the 15 stud- Table  2) .
Psychiatric conditions
Here, we summarize the studies on depression, anxiety, and/or mood together, because in most of the studies, questionnaires that tested multiple psychiatric conditions were used. Fifteen studies tested healthy participants with respect to anxiety, depression, distress levels, mood state, and behavior problems. 39, [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] The measurement tools included the General Health Questionnaire (GHQ), the Depression Anxiety and Stress Scale (DASS), the Leiden Index of Depression Sensitivity-Revised (LEIDS-r), the Positive and Negative Symptom Scale (PANSS), the State-Trait Anxiety Inventory (STAI), the Development Behavior Checklist (DBC), the Beck Depression Inventory (BDI), the Beck Anxiety Inventory (BAI), the Hopkins Symptom Checklist (HSCL-90), the Hospital Anxiety and Depression Scale (HADS), the Perceived Stress Scale (PSS), the Coping Checklist (CCL) (also used to counter the stress of daily life), and the questionnaire-based Profile of Mood State (POMS). Due to the different questionnaires, scales, and their combinations used in these studies, we only report here whether the probiotics treatment improved mental health/mood. One study compared a probiotic capsule (containing Lactobacillus casei, L. acidophilus, L. rhamnosus, Lactobacillus bulgaricus, B. breve, B. longum, and Streptococcus thermophilus) and a probiotic yogurt (containing B. lactis and L. acidophilus) with the combination of conventional yogurt and a placebo capsule, and found the former two were more effective in alleviating distress, anxiety, and depression in petrochemical workers. 52 A recent study using multi-strain probiotics found improvement in the LEIDS-r score, which is predictive of depression. 53 Two studies by Messaoudi et al 39, 61 found probiotic formulations of B. longum and L. helveticus could improve anxiety and depression in all participants, and also in those who had lower urinary free cortisol levels at baseline. One study using L. casei Shirota-containing milk improved mood only in the bottom third of the depressed distribution at baseline. 62 A study in chronic fatigue syndrome patients also used L. casei Shirota and found decreased anxiety levels following treatment. 51 One recent study, also using L. casei Shirota, found decreased salivary cortisol levels in university students in response to stress, although no significant difference in STAI score was observed. 50 However, other studies found no significant effect of their probiotic interventions. Patients with schizophrenia showed no change in PANSS score after treatment with L. rhamnosus for 14 weeks. 54 Patients with rheumatoid arthritis showed no change in anxiety levels, as assessed with the STAI after 8 weeks of L. casei. 55 Three studies conducted in IBS patients all looked into HADS scores before and after interventions, but found no effect of L. casei or fermented milk with L. paracasei and L. acidophilus. [56] [57] [58] In healthy male smokers, a 3-week intervention with L. casei showed no effect on STAI score. 59 In children with ASD, a 3-week intervention with L. plantarum did not change the DBC score.
60
Memory and other cognitive abilities
The study of Benton et al 62 measured different memory and cognitive abilities in healthy participants, including episodic memory, tested with the Wechsler Memory Scale, retrieval from long-term memory, verbal fluency, eating-associated behavior, and premorbid intelligence, tested with the National Adult Reading Test. However, L. casei Shirota decreased memory abilities in all participants compared with the placebo, and had no effect on verbal fluency or eating-associated behavior.
Neuroimaging study
There was only one neuroimaging study, using functional magnetic resonance imaging (fMRI), investigating the change in brain activity to emotional stimuli and basal brain activation after intake of a fermented milk product with probiotic (FMPP) containing B. lactis with yogurt starters, S. thermophilus, L. bulgaricus, and Lactococcus lactis subsp. lactis. 63 The FMPP decreased activity of a large distributed network including affective, viscerosensory, and somatosensory cortices to emotional faces, and changed midbrain connectivity during the resting state.
Mechanisms of action
Two studies found reduced cortisol levels in saliva and urine after probiotic interventions with L. casei Shirota and multi-strain L. helveticus + B. longum, respectively. 39, 50 The immune system could be improved by the probiotic L. casei, with evidence of reduced pro-inflammatory cytokines (TNF-a, IL-6, and IL-12), increased regulatory cytokines (eg, IL-10), and increased natural killer cell activity in smokers. 55, 59 Only one study in humans investigated metabolites of the tryptophan pathway but did not find any significant change by probiotics. 52 Many of the human studies looked at bowel function, and they did find reduced difficulties in bowel movement, IBS severity, and symptoms in patients. 54, 56, 58, 60 Microbiota analysis helped to confirm that fecal microbiota were altered by probiotic intervention: Lactobacillus was increased and Clostridium decreased by L. plantarum, whereas Bifidobacteria and Lactobacillus were increased by L. casei Shirota. 51, 60 More details are shown in Table 2 .
Summarizing all the studies in animals and humans that focused on CNS functions, including psychiatry conditions (anxiety and depression) and memory abilities, Bifidobacterium and Lactobacillus were the probiotics used most frequently. Doses ranged from 10 7 to 4 × 10 10 CFU per day and most studies used 10 9 and 10 10 CFU in animals and 3 × 10 9 CFU in humans. The duration of intake ranged from 1 week to 6 months with the most frequent durations of 2 weeks in animals and 4 weeks in humans.
Discussion
The number of studies using probiotics to improve central nervous system function has increased over the past 10 years, though with a focus on effects in animals. Researchers have used various strains of probiotics and studied various CNS functions. Summarizing the divergent findings motivated us to perform a systematic review of this research area. Previously, there was no systematic review or meta-analysis of the effects of probiotics on CNS function in animals and humans. To date, there are a few reviews on probiotic effects on infantile colic, which may reflect peripheral nervous system action, and one recent study reviewing only human studies. [64] [65] [66] Similarly, among the 56 RCTs so far which tested probiotics in adults with IBS that have or have not shown effects on peripheral (bowel) functions, 15 none have investigated whether any CNS effect was affected or improved. We identified studies applying probiotics as single-or multiple-strain preparations in animals and humans.
Because of the diversity of the interventions and the CNS functions tested in these studies, we did not perform a meta-analysis.
Effects of Probiotics
Combining all the studies in animals and humans, probiotics appear to have a positive effect in improving central nervous system function. However, a publication bias toward positive results cannot be excluded. Based on currently available studies, we can see that most of the studies used Bifidobacterium and Lactobacillus preparations, and most of them were effective in improving specific CNS functions. Again, however, negative results in relation to other functions may have been unreported, even in otherwise positive studies. Doses of 10 9 and 10 10 CFU have been used in most studies showing an effect on behaviors. An intake of the probiotic for 2 weeks in animals and 4 weeks in humans is apparently sufficient to elicit measurable effects. B. longum, B. breve, B. infantis, L. helveticus, L. rhamnosus, L. plantarum, and L. casei were the most commonly used preparations in these studies, as single-or multi-strain preparations, all of which were able to improve anxiety, depression, and memory related behaviors, based on animal models. All of these probiotics are regarded as "good" bacteria, presumably inhibiting the growth of harmful bacteria or pathogens and/or improving the immune system. [67] [68] [69] These probiotics were also found to reduce the symptoms of gastrointestinal disease, such as irritable bowel syndrome. 15, 16, 58, 70 Probiotics may play an important role in gut-brain axis communication, thereby benefiting both the brain and the gut. While some studies found no significant effect of probiotic intervention, the evidence is inadequate to conclude that the interventions were ineffective because some difficulties and/or weak points exist. For example, schizophrenia as a severe mental illness, and being closely related to a genetic disposition, may be a case in which probiotics can hardly be expected to have a significant effect on changing symptoms. 54 Probiotic doses in some studies were below the supposed effective dosages (at least 10 9 CFU), such as 10 8 CFU in the study in rheumatoid arthritis patients and 10 6 , 5 × 10 7 , and 10 8 CFU in IBS patients. [55] [56] [57] [58] Also, in two studies, one in male smokers and one in children with ASD, the intervention periods were 3 weeks, shorter than the effective period, which seems to be 4 weeks, that can make a measurable effect. 59, 60 Also, caution is warranted when drawing conclusions from the human studies that used psychological questionnaires and/or scales rather than behavioral or neuropsychological experiments, resulting in subjective biases. The clinical efficacy of probiotic interventions and guidelines for their administration in diseases such as diarrhea, allergies, IBS, and inflammatory bowel disease has been addressed in previous reviews. 15, 71, 72 More studies investigating probiotic effects in mental disorders are needed.
Mechanisms of Action of Probiotic Effects
The current state-of-the-art suggests several mechanisms: the endocrine system, immune system, action of enteric neurons, and commensal bacteria (or their metabolic activity). This evidence has come primarily from preclinical studies, while a few clinical studies have analyzed cortisol and cytokine levels in saliva and plasma. The HPA axis activity has been linked closely to mood disorders and memory abilities. 73 Probiotics also alter CNS function indirectly through several other pathways. L. helveticus, B. infantis, and B. fragilis enhanced serum tryptophan (precursor of 5-HT) levels and reduced its metabolites. Most of the probiotics tested affected the immune system by decreasing pro-inflammatory cytokines and increasing antiinflammatory cytokines. Another important pathway through which probiotics may modulate CNS function is intestinal barrier permeability, which is essential for maintaining the immune and nervous systems. Increased intestinal barrier permeability is associated with psychiatric disorders, such as depression and autism, while it can be restored by probiotic formulations of B. longum and L. helveticus, along with improved CNS function. 31, 41, 77 According to the data reviewed, different probiotics exhibited several common effects; however, these effects were strain-dependent and occurred via different pathways at a lower level of the CNS. Thus, more studies are needed for clarify which probiotics target which central biochemical substances and behaviors. In clinical applications, interventions with a probiotics cocktail may have greater effects, because different probiotics may create their effects at the same time through different pathways. However, as yet, such an approach currently lacks clinical evidence. 15 
Translation of Animal Studies
There are many animal studies about the gut microbiome-brain interaction using germ-free, specific pathogen free (SPF), or gnotobiotic animals, colonization with specific microbiota, probiotic intake, and infections to deliberately alter the GM and to manipulate CNS function. 9, 29, 30, 35, 37, 45, [78] [79] [80] [81] [82] In humans, we are not able to adapt most of these models for ethical reasons. Ten of the animal studies included in our review used probiotics in animals whose health state had been disturbed by various manipulations, which included antibiotic treatment, gene knockout, inflammation, infection, maternal immune activation, hyperammonemia, and diabetic induction, and depression induced by myocardial infarction. All of the manipulations were aimed at inducing changes in CNS function, including anxiety and depression-like behavior, memory impairment, or ASD-like behaviors. In humans, interfering with the participants' healthy state is not an option. What is possible is to explore the GM composition, correlating it to certain behaviors, and using probiotics to manipulate the GM-brain interaction. It is also possible to temporarily affect single functions, such as the stress response at the central level or the GM composition by varying the food or drugs used. As yet, evidence from studies using probiotics is confined to animal studies. Validity estimates of probiotic intervention from human studies are still missing and thus need to be carried out. The translation of behavioral models from animals to humans has both possibilities and limitations. The tests used to measure anxiety in animals, such as the elevate plus/Barnes maze, light/ dark box, defensive burying, open field/arms, and step-down, have no equivalents in humans, and neither do tests such as the forced swim and maternal separation for inducing depression and negative mood. In human studies, measurements of anxiety and depression rely primarily on scales such as the HADS, which has accuracy issues due to subjectivity and emotional bias from the participants/patients. Moreover, it remains questionable whether the behavioral tests used in animals do, in fact, adequately reflect the assumed CNS dysfunction (anxiety, depression) in humans and, more specifically, in patients. This leads to a demand for appropriate behavioral tests of anxiety and depression not only for patients with psychiatric disorders but also for the healthy population, and for adequate behavioral measures in animals that match these functions and dysfunctions in humans.
In addition to behavioral measurements, neuroimaging methods may provide insights as to what is altered in the brain that causes behavioral changes after the consumption of probiotics. An emotional faces attention task used in the fMRI study of Tillisch et al 63 is one example: the brain response to emotional stimuli that may be related to psychiatric conditions was changed after a 4-week intake of probiotics. Learning and memory abilities can be tested via numerous paradigms in humans. For spatial memory, there are computerized versions of the Morris water maze (VMWT) and the Blue Velvet Arena (BVA), which is also a variant of the Morris water maze for humans. [83] [84] [85] [86] For non-spatial memory, object recognition tasks and fear conditioning have been used widely in humans. These memory tasks can be conducted in combination with neuroimaging experiments, such as fMRI and magnetoencephalography (MEG) experiments.
There are also several ways to experimentally induce stress in humans. The Trier Social Stress Test, developed 20 years ago, during which participants are asked to play a role in a job interview, or in performing a public speech, can effectively increase the HPA axis and sympathetic-adrenal-medullary activity. 87 Social stress can also be induced using the Cyberball paradigm, during which stress comes from social exclusion and/or ostracism. 88, 89 Noise as a stressor is easy to manipulate in a laboratory environment by exposing participants to unpleasant sounds so as to induce psychological stress. Cognitive tasks can also stimulate stress responses with the advantage of being able to study the stress level by measuring task performance. 90 Other and more physical stressors include cold pressor tasks, 91 heat pain, 92 and the CO 2 challenge test, inducing stress/ panic in participants by inhaling carbon dioxide-enriched air. 93 All of these have also been shown to be compatible with brain imaging studies.
Conclusions and Indications
We reviewed the effect of probiotics on the central nervous system in randomized controlled trials in animals and humans, and analyzed the possibility of translating animal models to human studies because few human studies have been conducted to date. According to the qualitative analyses of current studies, we can provisionally draw the conclusion that B. longum, B. breve, B. infantis, L. helveticus, L. rhamnosus, L. plantarum, and L. casei were most effective in improving CNS function, including psychiatric diseaseassociated functions (anxiety, depression, mood, stress response) and memory abilities. Doses between 10 9 and 10 10 CFU and durations of 2 weeks in animals and 4 weeks in humans have shown sufficient effects. Also, translations of animal studies to human studies may be applicable. Human studies can be conducted using the same probiotics and similar experimental paradigms in the emotional and neurocognitive domains. More experimental designs in humans should be developed, and more neuroimaging studies should be conducted rather than using only psychological questionnaires or scales. In addition to studies in healthy populations, clinical studies in patients with mental diseases would be worthwhile, because those with gastrointestinal disorders and psychiatric comorbidities, in general, appear to benefit from probiotic interventions.
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